Pharmacist Participation in Medical Homes Aids Outcomes

Share this content:
Pharmacist Participation in Medical Homes Aids Outcomes
Pharmacist Participation in Medical Homes Aids Outcomes

FRIDAY, Dec. 15, 2017 (HealthDay News) -- A program that integrates clinical pharmacists into established primary care medical home practices helps patients achieve better disease management for high blood pressure (HBP) and diabetes mellitus (DM), compared to usual care, according to a study published recently in the Journal of International Medical Research.

Kimberly D. Brunisholz, Ph.D., from Intermountain Healthcare in Salt Lake City, and colleagues retrospectively examined the effectiveness of the Intermountain Healthcare Collaborative Pharmacist Support Services (CPSS) program (2012 to 2015) among 359 adult patients diagnosed with DM and/or HBP. Patients were propensity-matched to a reference cohort of 999 participants.

The researchers found that, compared with the reference group, CPSS patients were 93 percent more likely to achieve a blood pressure goal <140/90 mm Hg, 57 percent more likely to achieve hemoglobin A1c values <8 percent, and 87 percent more likely to achieve both disease management goals. Across the entire study period, time-to-goal achievement showed increased separation between the study cohorts (P < 0.001), particularly at 180 days post-intervention (HBP: P < 0.001; DM: P < 0.05).

"CPSS participation is associated with significant improvement in achievement of disease management goals, time to achievement, and increased ambulatory encounters compared with the matched no-CPSS cohort," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »